English
Polski
Español
українська
Red flags in dyspepsia
When should dyspepsia become a clinical concern? What are the high-risk groups or red flags that should never be ignored in patients with dyspepsia?
2018-05-25
When should dyspepsia become a clinical concern? What are the high-risk groups or red flags that should never be ignored in patients with dyspepsia?
How do you select donors of fecal material for fecal microbiota transplantation?
Is compliance a problem in patients receiving the recommended Helicobacter pylori eradication regimens?
What bacterial strains should be present in fecal material used for fecal microbiota transplantation (FMT)? Do you select a donor on the basis of the bacterial strains present in the fecal material?
Should the decision on surgical treatment of a pancreatic pseudocyst be based on its size (eg, diameter >5 cm) or symptoms caused by the cyst?
The Maastricht/Florence consensus does not contain any comprehensive list of indications for H pylori testing, unlike the recent ACG guidelines. In the light of the somewhat obscure statement saying that “H pylori gastritis is an infectious disease irrespective of symptoms and complications,” should we attempt to diagnose and eradicate H pylori only in patients with suspected infection or rather in everyone?
What are the most important systemic complications influencing the survival of patients with cirrhosis?
It has already been several years since the wide adoption of new oral anticoagulants, such as dabigatran or rivaroxaban. Are we able to estimate how it has influenced the rate of gastrointestinal bleeding (GI) worldwide?
After the publication of the Kyoto global consensus report, we are faced with a new entity called Helicobacter pylori-associated dyspepsia. How to make an appropriate diagnosis of this condition?
What are the new technological advancements in the treatment of gastrointestinal bleeding?
